Industry, FDA Discuss Making CIR Program ‘More Robust’
This article was originally published in The Rose Sheet
Executive Summary
As the cosmetics industry works to instill confidence in product safety and the mechanisms in place to vet ingredients, the Personal Care Products Council recently met with FDA to talk about refining the Cosmetic Ingredient Review program. The trade group wants to establish CIR panel findings as a first-line resource for FDA, particularly if legislation advances that would direct the agency to evaluate cosmetic ingredients for safety.